Clinical Trials Browser

NCT05773274 2026-03-19

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

Phase 2 Recruiting

100 enrolled

EndocrineNET

Metastatic Digestive System Neuroendocrine Tumor G1

NCT05691465 2026-03-18

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Phase 2 Recruiting

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT04665739 2026-03-17

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Phase 2 Recruiting

70 enrolled

EndocrineNET

Advanced Lung Neuroendocrine Tumor

NCT03206060 2026-02-17

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

Phase 2 Recruiting

130 enrolled

CNSEndocrineNET

Hypertension, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

NCT06955169 2026-02-17

MOMENTUM-1

Phase 2 Recruiting

153 enrolled

CNS

Meningioma

NCT04954820 2026-02-05

ReLUTH

Phase 2 Recruiting

146 enrolled

EndocrineNET

Neuroendocrine Tumors, Disease Progression

NCT04082520 2025-12-11

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Phase 2 Recruiting

41 enrolled

CNS

Meningioma

NCT06326190 2025-09-16

LUMEN-1

Phase 2 Recruiting

136 enrolled

CNS

Meningioma

NCT01876771 2025-08-08

A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours

Phase 2 Recruiting

500 enrolled

Endocrine

Carcinoma, Neuroendocrine

NCT06395402 2025-07-22

LUMOD-ID

Phase 2 Recruiting

120 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT05583708 2025-05-23

iPRRT

Phase 2 Recruiting

18 enrolled

Dermatologic

Carcinoma, Merkel Cell

NCT04903899 2025-02-11

LuDO-N

Phase 2 Recruiting

24 enrolled

CNS

Neuroblastoma

NCT06607692 2024-10-21

LUPARPED

Phase 2 Recruiting

25 enrolled

CNSEndocrineNET

Adrenal Gland Neoplasms, Medulloblastoma, Meningioma, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors